Samalizumab (Anti-CD200)

Samalizumab (Anti-CD200) is a humanized monoclonal antibody that specifically targets CD200. It can be used for multiple myeloma and B-cell chronic lymphocytic leukemia research. MW :144.84 KD.
Supplier Selleck Chemicals
Product # A2632
Sku # A2632-1mg*5
Pricing 1mg*5, $970.00
Feedback